Fr
Patients
Patients First
Everything we do at ExCellThera is centered around our patients. Our commitment to patients and their families includes the development of cures, but also understanding the patient needs. We put patients first every time.
View our Programs

Clinical Trials

ExCellThera is developing novel curative therapies for patients with hematologic malignancies and other diseases. To learn more about our ongoing clinical trials, please view our program pipeline.

Contact us
Fr
Patients
Clinical Trials

ExCellThera is pioneering best-in-class clinical trials in various indications in an effort to get cures to patients in an effective and efficient manner.

 

ECT-001-CB.001

ECT-001 (UM171) Expanded Cord Blood Transplant in Patients in Need of an Allogeneic Stem Cell Transplant – https://clinicaltrials.gov/ct2/show/NCT02668315

 

ECT-001-CB.002

ECT-001 (UM171) Expanded Cord Blood Transplant In Patients With High-Risk Acute Leukemia/Myelodysplasia – https://clinicaltrials.gov/ct2/show/NCT03913026

 

ECT-001-CB.003

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma –  https://clinicaltrials.gov/ct2/show/NCT03441958

 

ECT-001-CB.004

ECT-001 (UM171) Expanded Cord Blood in US Patients With High Risk Leukemia/Myelodysplasia – https://clinicaltrials.gov/ct2/show/NCT04103879

 

ECT-001-CB.005

ECT-001 (UM171) Expanded Cord Blood Transplant in Patients With Sickle-Cell Disease – https://clinicaltrials.gov/ct2/show/NCT04594031 

 

ECT-001-CB.007

ECT-001 (UM171) Expanded Cord Blood Transplant in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies – https://clinicaltrials.gov/ct2/show/NCT04990323

Contact us